Revolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology

Seminars in Nuclear Medicine

Volumn 31, Issue 2, 2001, Pages 158-164

  Czerniecki, Brian J ^a   Bedrosian, Isabelle ^a   Faries, Mark ^a   Alavi, Abass ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CLINICAL PRACTICE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MELANOMA; PREOPERATIVE EVALUATION; REVIEW; SENTINEL LYMPH NODE; TECHNOLOGY;

EID: 0035052421     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/snuc.2001.21270     Document Type: Article

References (37)

1. An approach for the treatment of penile carcinoma
2. Technical details of intraoperative lymphatic mapping for early stage melanoma
3. The concept of sentinel node localizations: How it started
4. Gamma-probe-guided lymph node localization in malignant melanoma
5. Minimal access surgery for staging of malignant melanoma
6. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma
7. The use of intraoperative lymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma
8. Improved sentinel lymph node localization in patients with primary melanoma with use of radiolabeled colloid
9. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers
10. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents
11. Radiopharmaceuticals for lymphoscintigraphy: Including dosimetry and radiation considerations
12. Active macromolecule uptake by lymph node antigen-presenting cells: A novel mechanism in determining sentinel lymph node status
13. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2
14. Lymphoscintigraphy in oncology: A rediscovered challenge
15. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer
16. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes
17. Mammary lymphoscintigraphy in breast cancer
18. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer
19. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel node biopsy in patients with breast cancer
20. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer
21. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
22. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
23. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
24. Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
25. Intradermal blue dye to identify sentinel lymph node in breast cancer
26. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye
27. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma
28. Incidence of sentinel node metastasis in patients with thin primary melanoma (<1mm) with vertical growth phase
29. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or stage II melanoma
30. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4,682 patients
31. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrence?
32. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer
33. Findings from NSABP Protocol No. B-04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers
34. Examination of regional lymph nodes by sentinel node biopsy and molecular marker analysis provides new staging facilities in primary cutaneous melanoma
35. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients
36. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
37. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?